Circulating levels of soluble E-selectin, P-selectin and intercellular adhesion molecule-1 in patients with juvenile idiopathic arthritis

Journal of Rheumatology

Volumn 27, Issue 9, 2000, Pages 2246-2250

  De Benedetti, F ^a   Vivarelli, M ^a   Pignatti, P ^a   Oliveri, M ^a   Massa, M ^a   Pistorio, A ^a   Martini, A ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

E selectin; Intercellular adhesion molecule 1; Juvenile rheumatoid arthritis; Tumor necrosis factor; Tumor necrosis factor receptor

Indexed keywords

CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; PADGEM PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ADOLESCENT; ARTICLE; CELL ACTIVATION; CELL ADHESION; CHILD; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ACTIVITY; ENDOTHELIUM CELL; HUMAN; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CHILD, PRESCHOOL; E-SELECTIN; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-1; INTERLEUKIN-6; P-SELECTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033821914     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Adhesion molecules. A rheumatologic perspective
2. Adhesion molecules in autoimmune disease
3. Leukocyte-endothelial adhesion molecules
4. Soluble intercellular adhesion molecule-1 inhibits MCH-restricted specific T cell/tumor interaction
5. Clinical use of the measurement of soluble adhesion molecules in patients with autoimmune diseases
6. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban 1997
7. Plasma levels after oral methotrexate in children with juvenile rheumatoid arthritis
8. Correlation of serum interleukin 6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis
9. Circulating levels of interleukin-1β and of interleukin-1 receptor antagonist in systemic juvenile rheumatoid arthritis
10. Soluble TNF receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis
11. Assaying tumor necrosis factor concentrations in human serum. A WHO International Collaborative Study
12. Variable estimates of cytokine levels produced by commercial ELISA kits: Results using international cytokine standards
13. Soluble receptors for tumor necrosis factor in clinical laboratory diagnosis
14. Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure?
15. Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease
16. The origin of P-selectin as a circulating protein
17. Hypothesis: Is soluble P-selectin a new marker of platelet activation?
18. Circulating soluble selectins in Kawasaki disease
19. Evidence for intravascular coagulation in systemic onset, but not polyarticular, juvenile rheumatoid arthritis
20. Increase of activated factor VIIA and hemostatic molecular markers in juvenile chronic arthritis
21. Decreased fibrinolytic activity in juvenile chronic arthritis
22. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
23. Is systemic juvenile rheumatoid arthritis an interleukin-6 mediated disease?
24. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor-α antibody in rheumatoid arthritis
25. Effect of recombinant dimeric tumor necrosis factor receptor on the inflammatory responses to intravenous endotoxin in normal humans
26. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor α, and interleukin 6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy
27. Soluble tumor necrosis factor receptors p55 and p75 in the urine monitor disease activity and the efficacy of treatment of inflammatory bowel disease
28. Circulating plasma receptors for tumor necrosis factor in Malawian children with severe falciparum malaria
29. Soluble intercellular adhesion molecule-1, endothelial leukocyte adhesion molecule-1, and tumor necrosis factor receptor (55 kDa TNF-R) in patients with acute Plasmodium falciparum malaria